Loading data
ADGMNasdaq
| Unit: USD | FY2025 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | — | 300 k USD | — |
| Cost of revenue | 684 k USD | 1.31 m USD | — |
| Research and development expense | 10.64 m USD | 15.4 m USD | — |
| Selling, general and administrative expense | 10.57 m USD | 11.54 m USD | — |
| Operating profit | -21.89 m USD | -27.94 m USD | — |
| Profit before tax | -25.32 m USD | -36.59 m USD | — |
| Net income (reported basis) | -25.1 m USD | -36.6 m USD | — |
| Net income attributable to common shareholders | -25.08 m USD | -36.59 m USD | — |
| Basic earnings per share | -1.51 USD/share | -48.16 USD/share | — |
| Diluted earnings per share | -1.51 USD/share | -48.16 USD/share | -31.5 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.